Showing results (411-420 of 448) with videos related to

Sort By:
Pageof 45
The British Journal of Dermatology|April 22, 2004
Refined localization of dyschromatosis symmetrica hereditaria gene to a 9.4-cM region at 1q21-22 and a literature review of 136 cases reported in ChinaP P He, C D He, Y Cui, et al.
The Review of Scientific Instruments|August 6, 2020
Diagnostic development for parallel wave-number measurement of lower hybrid waves in EASTY F Wang, B J Ding, M H Li, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|July 6, 2025
[Comparison of magnetic resonance images of the temporomandibular joint using different coils]X J Zhang, T T Wu, Y Zhang, et al.
Neurology Perspectives|April 15, 2024
The social and occupational consequences of the COVID-19 pandemic among patients with multiple sclerosis in three distinct populations: A web-based cross-sectional surveyG-X Zhang, R-Z Zhao, W-T Zhang, et al.
Epidemiology and Infection|November 28, 2017
Impact of an intervention programme on knowledge, attitudes and practices of population regarding severe fever with thrombocytopenia syndrome in endemic areas of Lu'an, ChinaY Lyu, C-Y Hu, L Sun, et al.
The British Journal of Dermatology|April 26, 2019
TT genotype of rs10036748 in TNIP1 shows better response to methotrexate in a Chinese population: a prospective cohort studyK X Yan, Y J Zhang, L Han, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 19, 2011
Comparisons of clinical features of HLA-DRB1*07 positive and negative vitiligo patients in Chinese Han populationD-Y Hu, Y-Q Ren, K-J Zhu, et al.
The Review of Scientific Instruments|December 3, 2022
Simulations of neutral beam injection and ion cyclotron resonance heating synergy in high power EAST scenariosD K Yang, L Y Liao, Y H Li, et al.
Lupus|June 3, 2010
TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han populationC-F He, Y-S Liu, Y-L Cheng, et al.
Zhonghua Yi Xue Za Zhi|June 7, 2026
[Efficacy and safety of olorigliflozin monotherapy in patients with type 2 diabetes mellitus with poor glycemic control on diet and exercise interventions]Y F He, J H Ma, H F Wang, et al.
Pageof 45